Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048379A1 T-bet compositions and methods of use thereof
06/12/2003WO2003048371A2 Dna vaccine
06/12/2003WO2003048368A2 Plants having altered abscisic acid (aba) sensitivity
06/12/2003WO2003048366A1 Sivmac239 immunogenic plasmids and aids dna vaccine containing the same
06/12/2003WO2003048365A1 Fungal elicitor
06/12/2003WO2003048364A2 Ovomucoid promoter and methods of use
06/12/2003WO2003048361A2 P55pik
06/12/2003WO2003048360A1 NOVEL PROTEINS BINDING TO MAMMALIAN TARGET OF RAPAMYCIN (mTOR) AND GENES THEREOF
06/12/2003WO2003048358A1 Adipocyte differentiation-associated gene and protein
06/12/2003WO2003048348A2 Production of viruses, viral isolates and vaccines
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048341A2 Cap-gly domain structure and uses thereof
06/12/2003WO2003048339A2 Nucleic acid molecules from rice encoding rar1 disease resistance proteins and uses thereof
06/12/2003WO2003048334A2 Immunocytokines with modulated selectivity
06/12/2003WO2003048326A2 Methods and materials relating to novel polypeptides and polynucleotides
06/12/2003WO2003048322A2 Dna encoding orphan snorf4 receptor
06/12/2003WO2003048320A2 Novel motor protein of p. falciparum and methods for its use
06/12/2003WO2003048319A2 Nucleotide sequences encoding proteins conferring abiotic stress tolerance in plants
06/12/2003WO2003048312A2 TUMOR SUPPRESSORS ASSOCIATED WITH HUMAN CHROMOSOME 21q22
06/12/2003WO2003048305A2 Receptors and membrane-associated proteins
06/12/2003WO2003048304A2 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF
06/12/2003WO2003048299A2 Novel spore wall proteins and genes from microsporidia
06/12/2003WO2003048297A2 Regulation of human atp-binding cassette transporter 1 like-protein
06/12/2003WO2003048210A1 Fusion protein having enhanced in vivo erythropoietin activity
06/12/2003WO2003048206A2 Growth hormone agonist peptides and their uses
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048204A1 Alzheimer’s disease-associated gene and protein and use thereof
06/12/2003WO2003048203A1 Stereostructure of dna replication regulatory protein and use thereof
06/12/2003WO2003048202A2 Nf-kappab activating genes
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048200A1 Nuclear protein 'shoca' - a component of the wnt signalling pathway
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048198A2 Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof
06/12/2003WO2003048197A1 Production and of viruses, viral isolates and vaccines
06/12/2003WO2003048196A2 Means and methods for diagnosing and treating craniofacial malformations
06/12/2003WO2003048195A2 Glucose dependant release of insulin from glucose sensing insulin derivatives
06/12/2003WO2003048194A2 Peptide or protein containing a c'-d loop of the cd28 receptor family
06/12/2003WO2003048193A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
06/12/2003WO2003048192A1 Novel peptides and medicinal uses thereof
06/12/2003WO2003048188A2 15603, a human ion channel family member
06/12/2003WO2003048187A2 Peptides and use thereof in therapeutic agents against hiv infection
06/12/2003WO2003048186A2 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
06/12/2003WO2003048185A2 Angiopioetin related factors
06/12/2003WO2003048184A2 Flavivirus ns1 subunit vaccine
06/12/2003WO2003048178A2 Nucleotide analogues and their use for nucleic acid sequencing
06/12/2003WO2003048166A1 Podophyllotoxins as antiproliferative agents
06/12/2003WO2003047743A2 Method for the synthesis of uniquely d-peptides and peptide nucleic acids
06/12/2003WO2003047635A1 Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders
06/12/2003WO2003047616A1 Migration of hematopoietic stem cells and progenitor cells to th e liver
06/12/2003WO2003047613A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer
06/12/2003WO2003047532A2 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
06/12/2003WO2003047526A2 Cell adhesion and extracellular matrix proteins
06/12/2003WO2003047525A2 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
06/12/2003WO2003047507A2 Factor viii c2 domain variants
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003047421A2 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2003026399A3 Gng4 gene disruptions, compositions and methods related thereto
06/12/2003WO2003025175A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
06/12/2003WO2003020951A3 Identification of a novel group ii intron splicing factor
06/12/2003WO2003012070A3 Gene associated with bone disorders
06/12/2003WO2003008625A3 Structural and cytoskeleton-associated proteins
06/12/2003WO2002100894A3 Dna encoding a mutant peroxisome proliferator-activated receptor gamma coactivator-1 (pgc-1), detection methods and test kits therefor
06/12/2003WO2002068627A3 Vector constucts
06/12/2003WO2002061088A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
06/12/2003WO2002046442A3 Phosphatase stress-related proteins and methods of use in plants
06/12/2003WO2002020758A3 Novel proteins and nucleic acids encoding same
06/12/2003WO2002016623A8 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003WO2001088126A8 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
06/12/2003WO2001083701A8 Light-driven energy generation using proteorhodopsin
06/12/2003US20030110537 Removal germ form seeds; transforming plant tissue
06/12/2003US20030110536 Controlling endosperm; modulation ofgene expression
06/12/2003US20030110534 Monocotyledon plant cells and plants which synthesise modified starch
06/12/2003US20030110533 Acetyl-CoA carboxylase subunits
06/12/2003US20030110529 Genetic engineering gene expression cassette; adjustment protein cell cycles; plants
06/12/2003US20030110528 Novel ecdysone receptors and methods for their use
06/12/2003US20030110525 Therapy for central nervous system disorders; culture product; transgenic animal
06/12/2003US20030110522 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the PSP94 gene
06/12/2003US20030110521 Anxiolytic agents; psychological disorders; insertion of genetic vector into nucleic acids, transcription
06/12/2003US20030110520 Isolation and characterization of a N. crassa silencing gene and uses thereof
06/12/2003US20030110519 Cognition activators, sleep disorders, eating disorders, psychological disorders
06/12/2003US20030110518 Melanocortin-5 receptor sequences and uses thereof
06/12/2003US20030109695 Genetic engineering of nucleic acids
06/12/2003US20030109694 Novel process
06/12/2003US20030109692 Protein G receptors; autoimmune disease, antidiabetic agents, anticancer agents
06/12/2003US20030109691 Variant integrin polypeptides and uses thereof
06/12/2003US20030109690 Colon and colon cancer associated polynucleotides and polypeptides
06/12/2003US20030109689 Using polypeptides; induction immunology response
06/12/2003US20030109686 Methods for evaluating tissue morphogenesis and activity
06/12/2003US20030109685 Schizophrenic, psychological disorders, Parkinson's disease; genetic engineered polypeptide
06/12/2003US20030109684 Antitumor agents; transforming growth factor
06/12/2003US20030109683 Hybrid proteins; controlling gene expression in gene therapy; Parkinson's disease
06/12/2003US20030109681 Polypeptide binding to antibody
06/12/2003US20030109679 Extraction, concentrating from aqueous solution
06/12/2003US20030109678 Methods and means for regulation of gene expression
06/12/2003US20030109677 TIE-2 ligands, methods of making and uses thereof
06/12/2003US20030109676 Human endothelin-bombesin receptor
06/12/2003US20030109675 Therapy for infections; enzyme inhibitors
1 ... 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 ... 2916